[go: up one dir, main page]

DE122010000032I1 - Ion enthaltend acyclovir und hydrokortison - Google Patents

Ion enthaltend acyclovir und hydrokortison

Info

Publication number
DE122010000032I1
DE122010000032I1 DE122010000032C DE122010000032C DE122010000032I1 DE 122010000032 I1 DE122010000032 I1 DE 122010000032I1 DE 122010000032 C DE122010000032 C DE 122010000032C DE 122010000032 C DE122010000032 C DE 122010000032C DE 122010000032 I1 DE122010000032 I1 DE 122010000032I1
Authority
DE
Germany
Prior art keywords
hydrocortison
ion contains
contains acyclovir
acyclovir
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE122010000032C
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir AB filed Critical Medivir AB
Publication of DE122010000032I1 publication Critical patent/DE122010000032I1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE122010000032C 1995-02-06 1996-02-02 Ion enthaltend acyclovir und hydrokortison Pending DE122010000032I1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500114 1995-02-06
PCT/SE1996/000124 WO1996024355A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutical combination

Publications (1)

Publication Number Publication Date
DE122010000032I1 true DE122010000032I1 (de) 2010-10-21

Family

ID=20396821

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69637828T Expired - Fee Related DE69637828D1 (de) 1995-02-06 1996-02-02 Pharmazeutische Formulierung zur topischen Anwendung enthaltend eine antivirale Substanz und ein Glucocorticoid
DE69632034T Expired - Lifetime DE69632034T2 (de) 1995-02-06 1996-02-02 Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison
DE122010000032C Pending DE122010000032I1 (de) 1995-02-06 1996-02-02 Ion enthaltend acyclovir und hydrokortison

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69637828T Expired - Fee Related DE69637828D1 (de) 1995-02-06 1996-02-02 Pharmazeutische Formulierung zur topischen Anwendung enthaltend eine antivirale Substanz und ein Glucocorticoid
DE69632034T Expired - Lifetime DE69632034T2 (de) 1995-02-06 1996-02-02 Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison

Country Status (29)

Country Link
US (2) USRE39264E1 (de)
EP (2) EP0809498B1 (de)
JP (2) JP4260220B2 (de)
KR (1) KR100431042B1 (de)
CN (1) CN1131034C (de)
AR (1) AR002030A1 (de)
AT (2) ATE421358T1 (de)
AU (1) AU716809B2 (de)
CA (1) CA2211389C (de)
DE (3) DE69637828D1 (de)
DK (1) DK0809498T3 (de)
DZ (1) DZ1966A1 (de)
ES (1) ES2214528T3 (de)
FI (1) FI119415B (de)
FR (1) FR10C0038I2 (de)
HR (1) HRP960034B1 (de)
IL (1) IL116913A0 (de)
MA (1) MA23800A1 (de)
MY (1) MY119365A (de)
NO (1) NO314220B1 (de)
NZ (1) NZ301407A (de)
PT (1) PT809498E (de)
SA (1) SA96160590B1 (de)
SI (1) SI0809498T1 (de)
TN (1) TNSN96024A1 (de)
TW (1) TW438585B (de)
WO (1) WO1996024355A1 (de)
YU (1) YU49477B (de)
ZA (1) ZA96527B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US7618950B2 (en) * 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
WO2006105216A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
EP1871349A1 (de) * 2005-04-11 2008-01-02 Nanobio Corporation Quartäre ammoniumhalogenide zur behandlung von infektionskrankheiten
WO2008051186A2 (en) * 2005-08-09 2008-05-02 Nanobio Corporation Nanoemulsion containing compositions having ant i -inflammatory activity
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
FR2900577B1 (fr) * 2006-05-04 2008-09-12 Goemar Lab Sa Nouveaux medicaments pour les traitements contre le virus de l'herpes
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP2066661A2 (de) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
EP1958947A1 (de) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitoren für Phosphodiesterase Typ 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2155209A4 (de) * 2007-04-26 2012-06-13 Univ Pennsylvania Dna-polymerase-inhibitorzusammensetzung und verfahren
EP2152304B1 (de) 2007-05-02 2018-08-22 The Regents of the University of Michigan Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
US20090291895A1 (en) * 2008-05-23 2009-11-26 Wong Scott W Methods and Compositions for the Treatment of Inflammatory Diseases
US20110065655A1 (en) * 2009-09-17 2011-03-17 Karry Whitten Therapeutic composition to treat lesions caused by herpes simplex virus
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
EP2489354A1 (de) 2011-02-18 2012-08-22 Vironova AB Pharmazeutische Formulierung enthaltend B220 zur topischen Behandlung von Herpes
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
TWI629062B (zh) 2013-03-13 2018-07-11 香港商安能泰製藥有限公司 含有局部麻醉劑之局部用抗病毒組合物及其製備方法
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona
EP3982927A1 (de) 2019-06-14 2022-04-20 Propella Therapeutics, Inc. Topische acyclovirformulierungen und verwendungen davon
KR102478608B1 (ko) * 2019-06-25 2022-12-19 아주대학교산학협력단 허피스 감염증 마우스 모델의 제조방법
CN112569243A (zh) * 2019-09-30 2021-03-30 神农医药科技有限公司 制备治疗阿尔茨海默病的药物
EP4149443A4 (de) * 2020-05-11 2024-05-29 Revir, Inc. Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en) 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine
GB2636847A (en) * 2023-12-22 2025-07-02 Vivian Cridland John Treatment of viral infection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) * 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0594224A3 (en) 1985-09-17 1994-07-13 Wellcome Found Therapeutic nucleosides
US5023090A (en) 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
AU636255B2 (en) 1990-11-05 1993-04-22 Arthropharm Pty Ltd Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
DE69232706T2 (de) * 1991-05-01 2002-11-28 Henry M. Jackson Foundation For The Advancement Of Military Medicine, Rockville Verfahren zur behandlung infektiöser respiratorischer erkrankungen
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
HK1004368A1 (en) 1998-11-27
YU49477B (sh) 2006-05-25
HRP960034A2 (en) 1997-10-31
FR10C0038I1 (de) 2010-10-15
SI0809498T1 (en) 2004-12-31
HRP960034B1 (en) 2002-02-28
NO973612D0 (no) 1997-08-05
IL116913A0 (en) 1996-05-14
SA96160590B1 (ar) 2005-10-05
TNSN96024A1 (fr) 2005-03-15
NO973612L (no) 1997-09-26
FR10C0038I2 (de) 2011-04-29
FI119415B (fi) 2008-11-14
DZ1966A1 (fr) 2002-10-15
USRE39264E1 (en) 2006-09-05
KR19980701959A (ko) 1998-06-25
FI973243A0 (fi) 1997-08-06
JP4260220B2 (ja) 2009-04-30
DE69637828D1 (de) 2009-03-12
TW438585B (en) 2001-06-07
EP1419803A3 (de) 2004-06-09
DK0809498T3 (da) 2004-05-10
CN1179718A (zh) 1998-04-22
ZA96527B (en) 1996-08-06
AU716809B2 (en) 2000-03-09
NZ301407A (en) 1999-01-28
CA2211389A1 (en) 1996-08-15
NO314220B1 (no) 2003-02-17
DE69632034D1 (de) 2004-05-06
ATE421358T1 (de) 2009-02-15
ATE262907T1 (de) 2004-04-15
JPH11506417A (ja) 1999-06-08
YU7296A (sh) 1998-08-14
JP2007284452A (ja) 2007-11-01
ES2214528T3 (es) 2004-09-16
MY119365A (en) 2005-05-31
WO1996024355A1 (en) 1996-08-15
EP0809498A1 (de) 1997-12-03
MA23800A1 (fr) 1996-10-01
PT809498E (pt) 2004-06-30
EP0809498B1 (de) 2004-03-31
CN1131034C (zh) 2003-12-17
AR002030A1 (es) 1998-01-07
KR100431042B1 (ko) 2004-06-16
AU4682196A (en) 1996-08-27
US6337324B1 (en) 2002-01-08
CA2211389C (en) 2007-11-20
EP1419803B1 (de) 2009-01-21
DE69632034T2 (de) 2004-10-14
EP1419803A2 (de) 2004-05-19
FI973243L (fi) 1997-08-06

Similar Documents

Publication Publication Date Title
DE122010000032I1 (de) Ion enthaltend acyclovir und hydrokortison
DE69615461D1 (de) Verbinder und Abdeckung dafür
DE69627188D1 (de) Brille und brillenfassung
DE69608973D1 (de) Schalter und diesen enthaltende Schaltungsanordnung
FI951910A0 (fi) Ioniliikespektrometri
ATE206445T1 (de) Rheologisch modifizierte polyolefine
DE69625256D1 (de) Mikrorechner
DE69617978D1 (de) Achsschenkel
DE69604220D1 (de) Luftentfeuchter
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DE69526002D1 (de) Aufladegerät und Aufladevorrichtung
DE69518687D1 (de) Versorgung-unterscheidendes und Versorgung-adaptierendes elektronisches System
DE69702027D1 (de) Leitfähiger Überzug und Glaszusammensetzung
GB9423372D0 (en) Proteins and their uses
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
DE69614442D1 (de) Mikrorechner
KR960010685A (ko) 펩티드 및 그 용도
DE19781531T1 (de) Drosselkörper und Herstellungsverfahren dafür
NO965218D0 (no) Styre- og manövreringsstikke
FI955905A7 (fi) Trifunktionaalisia trombiinivastaisia ja verihiutalevastaisia peptidejä
IT1273941B (it) Interruttore elettrico e metodo di realizzazione dello stesso
NO974189D0 (no) Skinne
KR970038981U (ko) 자화수기
FI960739A0 (fi) Sil
KR970018929U (ko) 제습겸용 가습기